pharma · Dengue Fever · Chronic Babesiosis · SXTP
60 DEGREES PHARMACEUTICALS
60 DEGREES PHARMACEUTICALS, INC.
60 Degrees Pharmaceuticals is a pharma organization headquartered in Washington, USA. It trades on NYSE under ticker SXTP. Primary therapeutic focus areas include Dengue Fever, Chronic Babesiosis, Babesiosis, COVID 19 Di
Washington, USA HQ
2010 Founded
6 Employees
Public company Type
SXTP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Washington, USA
- Founded
- 2010
- Employees
- 6
- Programs
- 5
- Drugs
- 2
- Patents
- 0
Tafenoquine
Phase 2 · small molecule · Babesiosis
Tafenoquine for Babesiosis is a Phase 2 program (small_molecule) at 60 DEGREES PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Internal code TQ-BA-2024-1
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- 60 DEGREES PHARMACEUTICALS, INC.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Babesiosis
- Status
- active
- Trials
- 1